ICL Selling General Administrative from 2010 to 2025

ICL Stock  USD 5.69  0.13  2.23%   
ICL Israel Selling General Administrative yearly trend continues to be quite stable with very little volatility. Selling General Administrative may rise above about 367.1 M this year. From the period between 2010 and 2025, ICL Israel, Selling General Administrative regression line of its data series had standard deviation of  239,632,249 and standard deviation of  239,632,249. View All Fundamentals
 
Selling General Administrative  
First Reported
2001-09-30
Previous Quarter
63 M
Current Value
68 M
Quarterly Volatility
120.3 M
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check ICL Israel financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among ICL Israel's main balance sheet or income statement drivers, such as Depreciation And Amortization of 625.8 M, Interest Expense of 121.3 M or Selling General Administrative of 367.1 M, as well as many indicators such as Price To Sales Ratio of 1.86, Dividend Yield of 0.0413 or PTB Ratio of 1.06. ICL financial statements analysis is a perfect complement when working with ICL Israel Valuation or Volatility modules.
  
Check out the analysis of ICL Israel Correlation against competitors.

Latest ICL Israel's Selling General Administrative Growth Pattern

Below is the plot of the Selling General Administrative of ICL Israel Chemicals over the last few years. It is ICL Israel's Selling General Administrative historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in ICL Israel's overall financial position and show how it may be relating to other accounts over time.
Selling General Administrative10 Years Trend
Slightly volatile
   Selling General Administrative   
       Timeline  

ICL Selling General Administrative Regression Statistics

Arithmetic Mean387,809,911
Geometric Mean345,780,626
Coefficient Of Variation61.79
Mean Deviation152,510,795
Median305,526,000
Standard Deviation239,632,249
Sample Variance57423.6T
Range782.1M
R-Value(0.51)
Mean Square Error45455.8T
R-Squared0.26
Significance0.04
Slope(25,723,278)
Total Sum of Squares861354.2T

ICL Selling General Administrative History

2025367.1 M
2024259 M
2023260 M
2022291 M
2021276 M
2020232 M
2019254 M

About ICL Israel Financial Statements

ICL Israel investors utilize fundamental indicators, such as Selling General Administrative, to predict how ICL Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Last ReportedProjected for Next Year
Selling General Administrative259 M367.1 M

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether ICL Israel Chemicals is a strong investment it is important to analyze ICL Israel's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact ICL Israel's future performance. For an informed investment choice regarding ICL Stock, refer to the following important reports:
Check out the analysis of ICL Israel Correlation against competitors.
You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.
Is Fertilizers & Agricultural Chemicals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of ICL Israel. If investors know ICL will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about ICL Israel listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.087
Dividend Share
0.193
Earnings Share
0.32
Revenue Per Share
5.303
Quarterly Revenue Growth
(0.05)
The market value of ICL Israel Chemicals is measured differently than its book value, which is the value of ICL that is recorded on the company's balance sheet. Investors also form their own opinion of ICL Israel's value that differs from its market value or its book value, called intrinsic value, which is ICL Israel's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because ICL Israel's market value can be influenced by many factors that don't directly affect ICL Israel's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between ICL Israel's value and its price as these two are different measures arrived at by different means. Investors typically determine if ICL Israel is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ICL Israel's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.